![Daniel Baker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Baker
Direttore/Membro del Consiglio presso
SHATTUCK LABS, INC.
Patrimonio netto: - $ in data 31/05/2026
Profilo
Daniel G.
Baker is currently an Independent Director at Shattuck Labs, Inc. and Artiva Biotherapeutics, Inc., both starting in 2025.
Dr. Baker is also the Chief Development Officer at Cue Biopharma, Inc. since 2024.
Formerly, Dr. Baker was Chief Executive Officer & Director at Kira Biotech Pty Ltd. Dr. Baker was an Independent Non-Executive Director at Lakefront Biotherapeutics from 2022 to 2024.
From 2000 to 2019, Dr. Baker was Vice President-Immunology R&D at Johnson & Johnson.
Dr. Baker earned a doctorate from the University of Pennsylvania and completed undergraduate studies at Gettysburg College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Daniel Baker
| Società | Posizione | Inizio |
|---|---|---|
| CUE BIOPHARMA, INC. | Corporate Officer/Principal | 25/11/2024 |
| ARTIVA BIOTHERAPEUTICS, INC. | Direttore/Membro del Consiglio | 28/01/2025 |
| SHATTUCK LABS, INC. | Direttore/Membro del Consiglio | 25/08/2025 |
Precedenti posizioni note di Daniel Baker
| Società | Posizione | Fine |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Direttore/Membro del Consiglio | 06/10/2024 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2019 |
Kira Biotech Pty Ltd.
 Kira Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders | Amministratore Delegato | - |
Formazione di Daniel Baker
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gettysburg College
 Gettysburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Kira Biotech Pty Ltd.
Kira Biotech Pty Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops novel immunomodulatory compounds for the treatment of immune system disorders | Health Technology |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
